Neurocrine Biosciences Inc (NAS:NBIX)
$ 136.53 -0.46 (-0.34%) Market Cap: 13.82 Bil Enterprise Value: 12.85 Bil PE Ratio: 36.60 PB Ratio: 5.08 GF Score: 88/100

Q4 2019 Neurocrine Biosciences Inc Earnings Call Transcript

Feb 04, 2020 / 09:30PM GMT
Release Date Price: $103.1 (+2.64%)
Operator

Good day, everyone, and welcome to the Neurocrine Biosciences Fourth Quarter and Year-end 2019 Results Call. (Operator Instructions) Please note, today's call will be recorded. (Operator Instructions)

It is now my pleasure to turn the program over to Kevin Gorman, CEO of Neurocrine Biosciences. Please go ahead.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Thank you very much, operator. And thank you, everyone, for joining us here this afternoon. Today, I have Eiry Roberts, our Chief Medical Officer; Eric Benevich, Chief Commercial Officer; Matt Abernethy, CFO; Kyle Gano, our Head of BD and Strategy; and Todd Tushla, our Head of IR, with me.

Before we start out, Todd could you read our safe harbor statement.

Todd Tushla
Neurocrine Biosciences, Inc. - VP of IR

Yes. Good afternoon, everyone. Certain statements made in the course of this conference call that are not historical statements may be forward-looking statements, which are subject to risks and uncertainties.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot